Long-term regulation of cyclic nucleotide phosphodiesterase type 3B and 4 in 3T3-L1 adipocytes

Biochemical and Biophysical Research Communications

Volumn 353, Issue 4, 2007, Pages 1080-1085

  Oknianska, Alina ^a   Zmuda Trzebiatowska, Emilia ^a   Manganiello, Vincent ^b   Degerman, Eva ^a  

^a LUND UNIVERSITY   (Sweden)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Adipocyte; Insulin; Isoproterenol; Phosphodiesterase 3B; Phosphodiesterase 4

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; INSULIN; ISOBUTYLMETHYLXANTHINE; ISOENZYME; N CYCLOHEXYL 4 (1,2 DIHYDRO 2 OXO 6 QUINOLYLOXY) N (2 HYDROXYETHYL)BUTYRAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHODIESTERASE; PHOSPHODIESTERASE 3B; PHOSPHODIESTERASE 4D; PHOSPHODIESTERASE III; PHOSPHODIESTERASE IV; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION REGULATION; LIPID METABOLISM; LONG TERM CARE; METABOLIC REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; 3T3-L1 CELLS; ADIPOCYTES; ADRENERGIC BETA-AGONISTS; ANIMALS; BLOTTING, WESTERN; CHROMONES; DIOXOLES; DOWN-REGULATION; ENZYME INHIBITORS; INSULIN; ISOPROTERENOL; MICE; MORPHOLINES; TIME FACTORS; UP-REGULATION;

EID: 33846184759     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.141     Document Type: Article

References (30)

1. Soderling S.H., and Beavo J.A. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr. Opin. Cell. Biol. 12 (2000) 174-179
2. Francis S.H., Turko I.V., and Corbin J.D. Cyclic nucleotide phosphodiesterases: relating structure and function. Prog. Nucleic Acid Res. Mol. Biol. 65 (2001) 1-52
3. Schmitz-Peiffer C., Reeves M.L., and Denton R.M. Characterization of the cyclic nucleotide phosphodiesterase isoenzymes present in rat epididymal fat cells. Cell. Signal. 4 (1992) 37-49
4. Zmuda-Trzebiatowska E., Oknianska A., Manganiello V., and Degerman E. Role of PDE3B in insulin-induced glucose uptake, GLUT-4 translocation and lipogenesis in primary rat adipocytes. Cell. Signal. 18 (2006) 382-390
5. Shakur Y., Holst L.S., Landstrom T.R., Movsesian M., Degerman E., and Manganiello V. Regulation and function of the cyclic nucleotide phosphodiesterase (PDE3) gene family. Prog. Nucleic Acid Res. Mol. Biol. 66 (2001) 241-277
6. Y. Choi, S. Park, S. Hockman, E Zmuda-Trzebiatowska., F. Svennelid, M. Haluzik O., Gavrilova L., Peppin, M. Napolitano, M. Taira, F. Ahmad L.S., Holst, E. Degerman, V. Manganiello, Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice, J. Clin. Invest., in press.
7. Degerman E., Smith C.J., Tornqvist H., Vasta V., Belfrage P., and Manganiello V.C. Evidence that insulin and isoprenaline activate the cGMP-inhibited low-Km cAMP phosphodiesterase in rat fat cells by phosphorylation. Proc. Natl. Acad. Sci. USA 87 (1990) 533-537
8. Nagaoka T., Shirakawa T., Balon T.W., Russell J.C., and Fujita-Yamaguchi Y. Cyclic nucleotide phosphodiesterase 3 expression in vivo: evidence for tissue-specific expression of phosphodiesterase 3A or 3B mRNA and activity in the aorta and adipose tissue of atherosclerosis-prone insulin-resistant rats. Diabetes 47 (1998) 1135-1144
9. Tang Y., Osawa H., Onuma H., Hasegawa M., Nishimiya T., Ochi M., and Makino H. Adipocyte-specific reduction of phosphodiesterase 3B gene expression and its restoration by JTT-501 in the obese, diabetic KKAy mouse. Eur. J. Endocrinol. 145 (2001) 93-99
10. Tang Y., Osawa H., Onuma H., Nishimiya T., Ochi M., Sugita A., and Makino H. Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse. Diabetes Res. Clin. Pract. 54 (2001) 145-155
11. Rahn-Landstrom T., Mei J., Karlsson M., Manganiello V., and Degerman E. Down-regulation of cyclic-nucleotide phosphodiesterase 3B in 3T3-L1 adipocytes induced by tumour necrosis factor alpha and cAMP. Biochem. J. 346 (2000) 337-343
12. Mei J., Holst L.S., Landstrom T.R., Holm C., Brindley D., Manganiello V., and Degerman E. C(2)-ceramide influences the expression and insulin-mediated regulation of cyclic nucleotide phosphodiesterase 3B and lipolysis in 3T3-L1 adipocytes. Diabetes 51 (2002) 631-637
13. Elks M.L., Manganiello V.C., and Vaughan M. Hormone-sensitive particulate cAMP phosphodiesterase activity in 3T3-L1 adipocytes. Regulation of responsiveness by dexamethasone. J. Biol. Chem. 258 (1983) 8582-8587
14. Snyder P.B., Esselstyn J.M., Loughney K., Wolda S.L., and Florio V.A. The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis. J. Lipid. Res. 46 (2005) 494-503
15. Houslay M.D. PDE4 cAMP-specific phosphodiesterases. Prog. Nucleic Acid Res. Mol. Biol. 69 (2001) 249-315
16. Lugnier C. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol. Ther. 109 (2006) 366-398
17. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
18. Taira M., Hockman S.C., Calvo J.C., Belfrage P., and Manganiello V.C. Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase. J. Biol. Chem. 268 (1993) 18573-18579
19. Manganiello V.C., Murad F., and Vaughan M. Effects of lipolytic and antilipolytic agents on cyclic 3′,5′-adenosine monophosphate in fat cells. J. Biol. Chem. 246 (1971) 2195-2202
20. Degerman E., Belfrage P., and Manganiello V.C. Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J. Biol. Chem. 272 (1997) 6823-6826
21. Dlaboga D., Hajjhussein H., and O'Donnell J.M. Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: comparison with rolipram. Brain Res. 1096 (2006) 104-112
22. Cherry J.A., and Davis R.L. Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement and affect. J. Comp. Neurol. 407 (1999) 287-301
23. Gronning L.M., Baillie G.S., Cederberg A., Lynch M.J., Houslay M.D., Enerback S., and Tasken K. Reduced PDE4 expression and activity contributes to enhanced catecholamine-induced cAMP accumulation in adipocytes from FOXC2 transgenic mice. FEBS Lett. 580 (2006) 4126-4130
24. Pirola L., Johnston A.M., and Van Obberghen E. Modulation of insulin action. Diabetologia 47 (2004) 170-184
25. Bhathena S.J. Relationship between fatty acids and the endocrine and neuroendocrine system. Nutr. Neurosci. 9 (2006) 1-10
26. Liu H., Tang J.R., Choi Y.H., Napolitano M., Hockman S., Taira M., Degerman E., and Manganiello V.C. Importance of cAMP-response element-binding protein in regulation of expression of the murine cyclic nucleotide phosphodiesterase 3B (Pde3b) gene in differentiating 3T3-L1 preadipocytes. J. Biol. Chem. 281 (2006) 21096-21113
27. Klemm D.J., Roesler W.J., Boras T., Colton L.A., Felder K., and Reusch J.E. Insulin stimulates cAMP-response element binding protein activity in HepG2 and 3T3-L1 cell lines. J. Biol. Chem. 273 (1998) 917-923
28. Ding B., Abe J., Wei H., Xu H., Che W., Aizawa T., Liu W., Molina C.A., Sadoshima J., Blaxall B.C., Berk B.C., and Yan C. A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis. Proc. Natl. Acad. Sci. USA 102 (2005) 14771-14776
29. Le Jeune I.R., Shepherd M., Van Heeke G., Houslay M.D., and Hall I.P. Cyclic AMP-dependent transcriptional up-regulation of phosphodiesterase 4D5 in human airway smooth muscle cells. Identification and characterization of a novel PDE4D5 promoter. J. Biol. Chem. 277 (2002) 35980-35989
30. Tilley D.G., and Maurice D.H. Vascular smooth muscle cell phenotype-dependent phosphodiesterase 4D short form expression: role of differential histone acetylation on cAMP-regulated function. Mol. Pharmacol. 68 (2005) 596-605